Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Item
http://www.wikidata.org/entity/Q58447614
Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts.The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.Effects of whole-grain rye porridge with added inulin and wheat gluten on appetite, gut fermentation and postprandial glucose metabolism: a randomised, cross-over, breakfast study.Does GLP-1 suppress its own basal secretion?Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?The New Biology and Pharmacology of Glucagon.2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies).Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance.Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetesGlucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?Why is it so difficult to measure glucagon-like peptide-1 in a mouse?A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite.Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx
P2860

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Item
http://www.wikidata.org/entity/Q58447614
description
im Juli 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 22 July 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2014
@uk
name
Specificity and sensitivity of ...... asurements in clinical studies
@en
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1
@nl
type
label
Specificity and sensitivity of ...... asurements in clinical studies
@en
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1
@nl
prefLabel
Specificity and sensitivity of ...... asurements in clinical studies
@en
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Specificity and sensitivity of ...... asurements in clinical studies
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698